120 related articles for article (PubMed ID: 11027980)
1. Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests.
Davies FE; Rawstron AC; Pratt G; Coupe R; Clarke D; Lubenko A; Short K; Perren TJ; Selby PJ; Maclennan S; Major K; Woodhead V; Robinson F; Child JA; Smith GM; Johnson PW; Morgan GJ
Hematol Oncol; 2000 Sep; 18(3):111-20. PubMed ID: 11027980
[TBL] [Abstract][Full Text] [Related]
2. Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells.
Burgess J; Mills B; Griffith M; Mansour V; Weaver CH; Schwartzberg LS; Snyder EL; Krause DS; Yanovich S; Prilutskaya M; Umiel T; Moss TJ
Cytotherapy; 2001; 3(4):285-94. PubMed ID: 12171717
[TBL] [Abstract][Full Text] [Related]
3. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation.
Cancelas JA; Querol S; Canals C; Picón M; Azqueta C; Solà C; Montes A; Amill B; Griera E; Inglés J; López JJ; Germà JR; García-López J
Transfusion; 1998; 38(11-12):1063-70. PubMed ID: 9838939
[TBL] [Abstract][Full Text] [Related]
5. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
7. CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections.
Altès A; Sierra J; Esteve J; Martín-Henao G; Marín P; Sureda A; Briones J; Martino R; Villamor N; Colomer D; Carreras E; Garcia J; Brunet S; Montserrat E
Exp Hematol; 2002 Jul; 30(7):824-30. PubMed ID: 12135682
[TBL] [Abstract][Full Text] [Related]
8. Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery.
Pedrazzoli P; Lanza A; Battaglia M; Da Prada GA; Zambelli A; Perotti C; Ponchio L; Salvaneschi L; Robustelli della Cuna G
Cancer; 2000 Jun; 88(12):2758-65. PubMed ID: 10870058
[TBL] [Abstract][Full Text] [Related]
9. Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL.
Paulus U; Schmitz N; Viehmann K; von Neuhoff N; Dreger P
Bone Marrow Transplant; 1997 Sep; 20(5):415-20. PubMed ID: 9339759
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer.
Preti RA; Lazarus HM; Winter J; Stadtmauer EA; Nadasi S; McMannis J; Karandish S; Jennis A; Goldberg SL; Pecora AL
Cytotherapy; 2001; 3(2):85-95. PubMed ID: 12028831
[TBL] [Abstract][Full Text] [Related]
11. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
Han X; Shi Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
[TBL] [Abstract][Full Text] [Related]
12. CD34+ subset and tumor cell quantitation by flow cytometry--step toward quality assessment of autografts in B cell malignancies.
Johnsen HE; Rasmussen T; Knudsen LM
Vox Sang; 1998; 74 Suppl 2():477-82. PubMed ID: 9704485
[TBL] [Abstract][Full Text] [Related]
13. Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
Krüger W; Gruber M; Hennings S; Fehse N; Fehse B; Gutensohn K; Kröger N; Zander AR
Bone Marrow Transplant; 1998 Apr; 21(7):665-71. PubMed ID: 9578305
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.
Mohr M; Dalmis F; Hilgenfeld E; Oelmann E; Zühlsdorf M; Kratz-Albers K; Nolte A; Schmitmann C; Onaldi-Mohr D; Cassens U; Serve H; Sibrowski W; Kienast J; Berdel WE
Clin Cancer Res; 2001 Jan; 7(1):51-7. PubMed ID: 11205918
[TBL] [Abstract][Full Text] [Related]
15. Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study.
McQuaker IG; Haynes AP; Anderson S; Stainer C; Owen RG; Morgan GJ; Lumley M; Milligan D; Fletcher J; Bessell EM; Davis JM; Russell NH
J Clin Oncol; 1997 Jun; 15(6):2288-95. PubMed ID: 9196142
[TBL] [Abstract][Full Text] [Related]
16. Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study.
Lemoli RM; Martinelli G; Olivieri A; Motta MR; Rizzi S; Terragna C; Leopardi G; Benni M; Ronconi S; Cantori I; Rondelli D; Mangianti S; Leoni P; Montanari M; Cavo M; Tura S
Br J Haematol; 1999 Nov; 107(2):419-28. PubMed ID: 10583236
[TBL] [Abstract][Full Text] [Related]
17. Combined positive/negative purging and transplantation of peripheral blood progenitor cell autografts in breast cancer patients: a pilot study.
Mapara MY; Körner IJ; Lentzsch S; Krahl D; Reichardt P; Dörken B
Exp Hematol; 1999 Jan; 27(1):169-75. PubMed ID: 9923456
[TBL] [Abstract][Full Text] [Related]
18. Combined isolation of CD34+ progenitor cells and reduction of B cells from peripheral blood by use of immunomagnetic methods.
Martín-Henao GA; Picón M; Rueda F; Amill B; Querol S; Gonzalez-Barca E; Ferrá C; Grañena A; García J
Transfusion; 2002 Jul; 42(7):912-20. PubMed ID: 12375665
[TBL] [Abstract][Full Text] [Related]
19. The CD19+ B-cell counts at peripheral blood stem cell mobilization determine different levels of tumour contamination and autograft purgability in low-grade lymphoma.
Straka C; Oduncu F; Drexler E; Mitterer M; Schnabel B; König A; Brack N; Nerl C; Emmerich B
Br J Haematol; 2002 Mar; 116(3):695-701. PubMed ID: 11849235
[TBL] [Abstract][Full Text] [Related]
20. Positive selection of autologous peripheral blood stem cells.
Lopez M; Beaujean F
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):71-86. PubMed ID: 11000984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]